Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerMarshall R. Posner, Robert I. Haddad, Diáne Hershock et al.|New England Journal of Medicine|2007Cited by 1.7k
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trialRobert I. Haddad, Marshall R. Posner, Anne O’Neill et al.|The Lancet Oncology|2013Cited by 748
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal CancerDavid G. Pfister, Gregory T. Wolf, Scott A. Laurie et al.|Journal of Clinical Oncology|2006Cited by 504
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialMarshall R. Posner, Kevin J. Cullen, Jochen H. Lorch et al.|Annals of Oncology|2011Cited by 487
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialJochen H. Lorch, Marshall R. Posner, Olga Goloubeva et al.|The Lancet Oncology|2011Cited by 447